The Scientist

» drug development and evolution

Most Recent

image: Week in Review: October 17–21

Week in Review: October 17–21

By | October 21, 2016

Report finds that pathologist involved in anonymous defamation case committed multiple acts of misconduct; growing eggs from stem cells; neutrophils’ role in metastasis; convergent evolution in birds

0 Comments

image: Cuban-U.S. Research Collaborations Easier Now

Cuban-U.S. Research Collaborations Easier Now

By | October 18, 2016

President Obama’s executive actions remove some of the red tape for American and Cuban scientists to work together.

0 Comments

image: Single-Celled Life Primed to Go Multicellular

Single-Celled Life Primed to Go Multicellular

By | October 17, 2016

The unicellular ancestor of animals may have harbored some of the molecular tools that its many-celled descendants use to coordinate and direct cell differentiation and function, scientists show.

0 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

image: How Plants Evolved Different Ways to Make Caffeine

How Plants Evolved Different Ways to Make Caffeine

By | September 21, 2016

Caffeine-producing plants use three different biochemical pathways and two different enzyme families to make the same molecule.

2 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Allergan Set to Buy Vitae

Allergan Set to Buy Vitae

By | September 16, 2016

The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.

0 Comments

image: Stingrays Chew Too

Stingrays Chew Too

By | September 15, 2016

Researchers observe stingrays moving their jaws to grind up prey, a behavior thought to be restricted to mammals.

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Opinion: WHO’s Silence on Cannabis
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Infant Microbiome: Vaginal Delivery Versus C-Section
Rockland